INITIATOR PHARMA: YEAR END REPORT 2019
Initiator Pharma's issue of units oversubscribed
Initiator Pharma (INIT) aktie | Videos - Börskollen
Pharma People on the Move: Fall 2022 Roundup – PharmaLive
Recent advancements in applications of ionic liquids in synthetic construction of heterocyclic scaffolds: A spotlight - ScienceDirect
Initiator Pharma A/S | Nordic Issuing
Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition - ScienceDirect
Invitation to subscribe for shares in
The Board of Directors of Initiator Pharma A/S decides on execution of previously communicated preferential rights issue
Initiator Pharma - Phase 2a study with IP2018 update
Seeing the light: New applications for light curable adhesives in medtech - Med-Tech Innovation
Adare Pharma Solutions | Contract Pharma
ANNUAL REPORT
Publication of memorandum
Initiator Pharma
Today, the subscription period begins in Initiator Pharma's rights issue
Biomedical researchers have a new treatment of erectile dysfunction on the way
Reactions | Free Full-Text | Recent Progresses in the Preparation of Chlorinated Molecules: Electrocatalysis and Photoredox Catalysis in the Spotlight
DLA Piper assists Initiator Pharma A/S with list change from Spotlight Stock Market to Nasdaq First North Growth Market Sweden | DLA Piper
